1. CAPITAL (Cardiovascular Percutaneous Intervention Trials) Research Group (S.P., P.D.S., O.A.-R., R.G.J., P.M., L.R., H.F., B.M., J.W., R.M., B.H.), University of Ottawa, Canada.
2. Division of Cardiology (S.P., P.D.S., O.A.-R., P.M., M.F., R.M., M.L., B.H.), University of Ottawa, Canada.
3. Heart Institute, School of Epidemiology, Public Health and Preventative Medicine (P.D.S., R.G.J., P.M., J.B., G.A.W.), University of Ottawa, Canada.
4. Division of Critical Care Medicine (P.D.S.), Ottawa Hospital, Canada.
5. Division of Internal Medicine (R.G.J.), Ottawa Hospital, Canada.
6. Division of Cardiac Surgery (H.T., T.A.-A., M.R., V.C.), University of Ottawa, Canada.
7. Azumio Inc, Redwood City, CA (P.K.).
8. Cardiovascular Research Methods Centre (J.B., G.A.W.), University of Ottawa, Canada.
9. Department of Cardiovascular Diseases, Mayo Clinic School of Medicine, Rochester, MN (T.S.).
10. Division of Cardiology, Knight Cardiovascular Institute, Oregon Health & Sciences University, Portland (J.A.M.).